Robitussin Peak Cold Nighttime Multi-symptom Cold
Pricing Report NDC 0031-8735-12

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Robitussin Peak Cold Nighttime Multi-symptom Cold (NDC 0031-8735-12) is $0.03693 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2015.

As a provided by Richmond Division Of Wyeth, this medication is distributed in a 1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.03693
Per ML

Effective Date
May 20, 2015
Data Status
As of Sep 30, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.02735 to $0.03870 per ML. Over this 2 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0278 - $0.0387
Market Volatility
39.31% Variance
Latest Trend
21.80%
Date Unit Price Unit Source Method Rate
Sep 23, 2015 $0.02888 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2015 $0.03693 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2015 $0.03693 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
May 20, 2015 $0.03693 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
May 20, 2015 $0.02736 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 20, 2015 $0.02736 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Mar 18, 2015 $0.03782 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 18, 2015 $0.03782 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Mar 01, 2015 $0.03870 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Mar 01, 2015 $0.02861 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 01, 2015 $0.02861 MLC/I - Chain or Independent PharmacyCode 3, 5, 6B - Brand
Jan 21, 2015 $0.03752 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 21, 2015 $0.03752 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Nov 19, 2014 $0.03659 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Nov 19, 2014 $0.03659 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
May 21, 2014 $0.03766 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
May 21, 2014 $0.03766 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Apr 23, 2014 $0.02778 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Apr 23, 2014 $0.02778 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Apr 23, 2014 $0.02778 MLC/I - Chain or Independent PharmacyCode 4, 5, 6B - Brand
Mar 19, 2014 $0.03585 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Mar 19, 2014 $0.03585 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
Mar 19, 2014 $0.02735 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 22, 2014 $0.03507 MLC/I - Chain or Independent PharmacyCode 1, 5, 6B - Brand
Jan 22, 2014 $0.03507 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand
May 23, 2013 $0.03625 MLC/I - Chain or Independent PharmacyCode 2, 5, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026